SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 31, 2000
LIFECELL CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 01-19890 76-0172936
(State Or Other (Commission (IRS Employer
Jurisdiction Of File Number) Identification No.)
Incorporation) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
One Millenium Way
Branchburg, New Jersey 08876
-----------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (908) 947-1100
<PAGE>
Item 5. Other Events and Regulation FD Disclosure.
On October 31, 2000, LifeCell Corporation issued the press release attached
to this Current Report on Form 8-K as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press release dated October 31, 2000.
Item 9. Regulation FD Disclosure.
LifeCell will announce its results of operations for the third quarter
ended September 30, 2000 on November 2, 2000 prior to the opening of regular
market trading.
LifeCell will conduct a conference call on Thursday, November 2, 2000 at
11:00 a.m. Eastern time to discuss its results of operations for the third
quarter ended September 30, 2000. The media and general public may listen to
the conference call by calling (800) 288-8975 for domestic calls and (612)
332-0725 for international calls. The conference call will be recorded and an
automated playback of the conference call will be available beginning at 5:00
p.m. Eastern time, on November 2, 2000 through November 9, 2000 by dialing (800)
475-6701 for domestic calls and (320) 365-3844 for international calls and
indicating the access code of 547138.
~2~
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LIFECELL CORPORATION
By: /s/ Steven T. Sobieski
----------------------------
Steven T. Sobieski
Chief Financial Officer
Date: October 31, 2000
~3~
<PAGE>
